Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

Tiger Gold Corp. (TSXV: TIGR) ("Tiger" or the "Company") is pleased to announce that its common shares have commenced trading today on the Frankfurt Stock Exchange ("FSE") under the ticker symbol D150 ...